LAURUSLABSLaurus Labs Limited
Convert to ideaPharmaceuticals & Biotechnology · Pharmaceuticals · CARE: AA (Stable)
The verdict combines business quality, price and timing. Sign in free to see it.
Sign in freeUp 0.8 this quarter.
Momentum from moving averages, Supertrend and RSI.
2 forensic issues found. Sign in to see which.
Valuation Metrics
Q2 FY2027Intrinsic value, Graham number and DCF against today's price
2 found · risk minor
Quality, growth, balance sheet and earnings quality behind the score
ⓘ Based on fundamental & forensic analysis. Always verify against official filings and consult a financial advisor.
Financial Metrics
Comparing Q2 FY2027 vs Q2 FY2026
| Quarter | Revenue | Net Profit | OPM | NPM | EPS | Int. Cover |
|---|---|---|---|---|---|---|
| Q2 FY2027 | ₹2206 Cr | ₹436 Cr | 28.23% | 19.77% | ₹8.17 | 14.4x |
| Q1 FY2027 | ₹2026 Cr | ₹362 Cr | 25.39% | 17.87% | ₹6.81 | 12.4x |
| Q4 FY2026 | ₹1812 Cr | ₹282 Cr | 21.53% | 15.57% | ₹5.17 | 9.9x |
| Q3 FY2026 | ₹1778 Cr | ₹252 Cr | 20.22% | 14.16% | ₹4.67 | 9.4x |
| Q2 FY2026 | ₹1653 Cr | ₹194 Cr | 17.10% | 11.76% | ₹3.61 | 7.7x |
| Q1 FY2026 | ₹1570 Cr | ₹162 Cr | 16.90% | 10.30% | ₹3.02 | 5.4x |
Momentum score, 1-year chart, moving averages, support and resistance.
Turnaround stage, and how each measure moved over 3 years against the company's own range.
Order wins, capex, pledges, rating actions and every material filing.
Management guidance, Q&A highlights and whether they delivered what they said.
The earnings call read across investor dimensions.
Promoter, FII and mutual fund holding, and what changed this quarter.
Similar-size peers in Pharmaceuticals
Compare with peers →Laurus Labs Limited, together with its subsidiaries, manufactures and sells medicines and active pharmaceutical ingredients (APIs) in India and internationally. The company offers Generics APIs and oral solid formulations for advanced intermediates for anti-retroviral (ARV), antidiabetic, cardiovascular, anti-asthma, ophthalmology, oncology, gastroenterology, and hepatitis C therapeutic areas. It also provides biotechnology services used in the nutraceutical, dietary supplements, alternate food proteins, and cosmeceutical products. In addition, the company develops novel enzymatic solutions for industrial biotechnology, and animal origin free recombinant proteins and enzymes for biopharma; and offers business support services for pharmaceuticals field. Laurus Labs Limited was incorporated in 2005 and is based in Hyderabad, India.
Note: This comprehensive analysis combines technical data, fundamental data, and investment thesis. Always do your own research and consider your personal risk tolerance before investing.